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Endoscopic retrograde cholangiopancreatography (ERCP):
outcomes of 3136 cases over 10 years
Sabri Selçuk ATAMANALP1, Mehmet İlhan YILDIRGAN1, Abdulmecit KANTARCI2

Aim: Endoscopic retrograde cholangiopancreatography (ERCP) has an important place in the diagnosis and treatment
of hepatobiliary and pancreatic diseases. This study discusses the outcomes of 3664 ERCPs in 3136 patients over the
course of 10 years.
Materials and methods: The records of 3664 ERCPs of 3136 patients, performed between January 2000 and January
2010, were retrospectively evaluated.
Results: The age range was 4-94 years (mean: 55.1 years), and 1816 patients (57.9%) were female. The most common
indication was the presence of obstructive jaundice and/or a high serum bilirubin level (2289 patients, 73.0%). The
average ERCP duration was 16.5 min (range: 5-45 min). A repeat ERCP was needed in 528 patients (16.8%), and
cannulation was successful in 2965 patients (94.5%). Endoscopic sphincterotomy was performed in 2797 patients
(89.2%), biliary balloon application in 2768 (88.3%), and stone extraction in 2231 (71.1%). Complications occurred
in 118 patients (3.8%), and the most common complication was acute pancreatitis (54 patients, 1.7%). In this series, 5
patients (0.2%) died.
Conclusion: Despite its associated morbidity and risk of mortality, ERCP is a reliable method in diagnosing and treating
hepatobiliary and pancreatic diseases.
Key words: Endoscopy, endoscopic retrograde cholangiopancreatography, general surgeon

Endoskopik retrograt kolanjiyopankreatografi (ERCP):
10 yılda 3136 olgunun sonuçları
Amaç: Endoscopik retrograt kolanjiyopankreatografi (ERCP) karaciğer-safra sistemi ve pankreas hastalıklarının tanı ve
tedavisinde önemli bir yere sahiptir. Bu çalışma, 10 yıllık bir sürede 3136 hastada uygulanan 3664 ERCP’nin sonuçlarını
tartışmaktadır.
Yöntem ve gereç: Ocak 2000-Ocak 2010 arasında 3136 hastada yapılan 3664 ERCP’nin kayıtları retrospektif olarak
değerlendirildi.
Bulgular: Yaş dağılımı 4-94 arasındaydı (ortalama 55,1 yıl) ve 1816 hasta (% 57,9) kadındı. En sık endikasyon tıkanma
sarılığı ve/veya yüksek serum bilirübin düzeyi varlığıydı (2289 hasta, % 73,0). Ortalama ERCP süresi 16,5 dakikaydı
(dağılım: 5-45 dakika). Tekrarlanan ERCP 528 hastada (% 16,8) gerekti ve kanülasyon 2965 hastada (% 94,5) başarılıydı.
Endoskopik sfinkterotomi 2797 hastada (% 89,2), biliyer balon uygulaması 2768’inde (% 88,3) ve taş çıkarılması
2231’inde (% 71,1) uygulandı. Komplikasyon 118 hastada (% 3,8) ortaya çıktı ve en sık komplikasyon akut pankreatitti
(54 hasta, % 1,7). Bu seride 5 hasta (% 0,2) öldü.
Sonuç: Morbidite ve mortalitesine rağmen ERCP, karaciğer-safra sistemi ve pankreas hastalığının tanı ve tedavisinde
güvenilir bir yöntemdir.
Anahtar sözcükler: Endoskopi, endoskopik retrograt kolanjiyopankreatografi, genel cerrah
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Introduction
Endoscopic retrograde cholangiopancreatography
(ERCP) is a useful technique for the diagnosis and
treatment of hepatobiliary and pancreatic diseases
(1,2). Despite technological progress, ERCP is
associated with several complications, including
pancreatitis, hemorrhage, perforation, cholangitis,
and cardiopulmonary events, that occur in up to 10%
of patients. ERCP has a mortality rate of up to 1% (2).
Although ERCP usually falls within the domain
of gastroenterologists, it can be performed safely by
trained surgeons (3). The purpose of this study was
to discuss the outcomes of 3664 ERCP procedures
performed in a general surgery department on 3136
patients over 10 years.
Materials and methods
In the General Surgery Department of Atatürk
University Medical School, 3664 ERCPs were
performed on 3136 patients by general surgeons
between January 2000 and January 2010. The records
of the patients were retrospectively reviewed for age
and gender, indications for ERCP, duration of the
procedure, success of ERCP, type and number of
additional therapeutic endoscopic procedures, and
associated morbidity and mortality of ERCP and
other endoscopic procedures.
After a 6- to 8-h starvation period, 5 mg of
midazolam (Dormicum) and 30 mg of pethidine
(Aldolan) were administered intravenously before
ERCP, and additional doses were applied when
needed. All patients were followed with pulse
oximetry during the procedures.
The following devices were used for ERCP and
other endoscopic procedures: Olympus TJF 240,
Storz 13881 PKS, Fujinon ED 450 XT 5 flexible
duodenoscopes, Olympus UES-10, and Storz
Autocon 50 electrocauters, with various ERCP
catheters, sphincterotomes, balloons, lithotripters,
forceps, and coagulation electrodes. All procedures
were performed by trained general surgery professors.
The outpatients who underwent diagnostic ERCP
were discharged after a 4- to 6-h follow-up, and
the patients who underwent additional endoscopic
therapeutic procedures were hospitalized for 1 day.
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The patients were told to call if any problems occurred.
Patients with complications were hospitalized, and
the appropriate medical and/or surgical treatments
were performed.
Results
The age range of the patients was 4-94 years
(mean: 55.1 years). Of 3136 patients, 1816 (57.9%)
were female, and 1320 (42.1%) were male.
The most common indications for ERCP were
the presence of obstructive jaundice and/or high
serum bilirubin level in 2289 patients (73.0%), high
serum cholestatic enzyme levels without obstructive
jaundice in 1052 patients (33.5%), and choledochal
stones in 997 patients (31.8%) (Table 1). At least 1 of
the serum cholestatic enzyme levels (AST, ALT, GGT,
or ALP) was high in a total 2951 patients (94.1%).
The average ERCP procedure duration was 16.5
min (range: 5-45 min). ERCP was performed once
in 2608 patients (83.2%), twice in 440 (14.0%),
and 3 times in 88 (2.8%); therefore, there were a
total of 3664 ERCPs performed in 3136 patients.
Cannulation was successful in 2965 patients (94.5%)
and impossible in 171 patients. The most common
causes of unsuccessful cannulation were patient
intolerance and premedication problems (n = 53,
31.0%) (Table 2). Precut sphincterotomies were
needed in 465 patients (14.8%), 336 of which were
needle-knife sphincterotomies, while the others were
transpancreatic sphincterotomies.
Additional therapeutic endoscopic procedures
were performed on 2913 patients (92.9%), including
endoscopic sphincterotomy in 2797 patients (89.2%),
biliary balloon application in 2768 (88.3%), biliary
stone extraction in 2231 (71.1%), biliary stenting
in 113 (3.6%) (nonmetallic stents in 110 cases and
metallic stents in 3 cases; main indications: biliary
leakage, biliary malignancy, or biliary stenosis),
biliary basket lithotripter application in 78 (2.5%),
and biliary or papillary dilatation in 27 (0.9%).
After excluding 910 patients (29.0%) with serum
amylase level elevation, post-ERCP complications
were seen in 118 patients (3.8%). The most common
complication was acute pancreatitis, which was
seen in 54 patients (1.7%) (Table 3). Additionally,
5 patients (0.2%) died. Causes of death included
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Table 1. Indications for ERCP.
Indication

Patients*

%

Obstructive jaundice and/or high serum bilirubin level

2289

73.0

High serum cholestatic enzyme levels without obstructive jaundice

1052

33.5

Choledochal stone

997

31.8

Wide choledoch

301

9.6

Hepatic cyst (hydatid or alveolar)

182

5.8

Pancreatitis

159

5.1

Cholangitis

101

3.2

Pancreatic tumor

43

1.4

Biliary leakage

42

1.3

Papillary tumor

29

0.9

Choledochal or biliary tract tumor

17

0.5

Hepatic tumor

12

0.4

Pancreatic leakage

7

0.2

Choledochal cyst

6

0.2

Pancreatic cyst

2

0.1

Patients

%

Patient intolerance or premedication problems

53

31.0

Stenosis of pylorus or duodenal bulbs

37

21.6

Presence of gastrectomy

28

16.4

Complete papillary obstruction

17

9.9

*In some patients more than one

Table 2. Causes of unsuccessful cannulation.

Cause

Presence of food in the stomach

14

8.2

Breaking down of the instruments

13

7.6

Papillary position abnormality

9

5.3

171

100.0

Total

perforation and peritonitis in 3 surgically treated
patients and premedication problems in 2 patients.

clear images of the hepatobiliary and pancreatic ducts.
It also has diagnostic importance and therapeutic
value for most diseases of these systems (1,2).

Discussion

Cholestasis, with abnormal liver function or
cholestatic tests, and cholestatic jaundice are common
indications for diagnostic ERCP (4,5). Some authors
describe ERCP as the gold standard for the diagnosis

ERCP is an important procedure for the diagnosis
and treatment of hepatobiliary and pancreatic
diseases. ERCP can provide direct visualization and
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Table 3. Complications of ERCP.

Complication

Patients*

%

Serum amylase level elevation
<2 times
>2 times
Acute pancreatitis
Surgical treatment requirement
Pseudocyst development

910
568
342
54
17
6

29.0
18.1
10.9
1.7
0.5
0.2

Bleeding
Transfusion requirement

22
3

0.7
0.1

Perforation
Surgical treatment requirement

18
10

0.6
0.3

Acute cholangitis
Surgical treatment requirement

13
5

0.4
0.2

Major premedication problems

11

0.4

*In some patients more than one

of biliary obstruction because of the limited diagnostic
yield of other modalities (4,6). Nevertheless, because
less invasive diagnostic modalities are available, such
as magnetic resonance cholangiopancreatography
(MRCP), ERCP’s role as the gold standard has been
reevaluated (4). Currently, some authors use MRCP as
their first choice; diagnostic ERCP is performed only
when there is a suspected hepatobiliary-pancreatic
disease in the absence of abnormal images. MRCP is
performed to avoid unnecessary trauma in patients,
and authors define ERCP as a safe, efficacious
therapeutic procedure (1,7). Their use of ERCP is
generally parallel to our practice.
Although ERCP is used successfully in the
diagnosis of choledocholithiasis, the question of the
best candidate for ERCP is still unresolved. Scaffidi
et al. (6) showed a 28% false negative rate and an
11% false positive rate for MRCP in the diagnosis
of choledochal stones. When combined with
endoscopic sphincterotomy (ES), ERCP is the most
likely primary treatment for choledocholithiasis
(1,4,5), which is in agreement with our clinical
experience with 2231 patients. ERCP/ES has
618

been shown to be highly effective in detecting and
removing choledochal stones before laparoscopic
cholecystectomy (8,9). ERCP helps to diagnose, and
when combined with ES and/or biliary stenting to
manage, postcholecystectomy residual choledochal
stones and postoperative biliary complications such
as bile duct injuries with bile leakage or stricture (1013), which is compatible with our practice in 42 of
the patients in this study. Although the role of ERCP
in acute biliary pancreatitis remains controversial,
ERCP is widely used both in the diagnosis and,
when combined with biliary/pancreatic ES and/or
stenting, the treatment of mild-moderate or severe
gallstone-associated acute pancreatitis (14-17).
ERCP is also used to diagnose and manage traumatic
acute pancreatitis (18), which is in agreement with
our application in 159 patients. ERCP is also used
in the screening, diagnosis, preoperative evaluation,
and palliative treatment of bile duct and pancreatic
cancers (19-21), as was shown in 89 patients in the
present study. Similarly, ERCP is utilized in patients
with suspected biliary atresia, avoiding unnecessary
surgical procedures in almost 25% of cases (22).
ERCP is also used in the diagnosis and treatment
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of hepatobiliary disorders, some of which include
hydatid disease, alveolar echinococcosis, fascioliasis,
hemobilia, biloma, and hepatic malignancies (23-27),
as demonstrated in our practice in 200 patients. The
indications of ERCP shown in our sample are similar
to those reported in the literature.
Because most ERCP complications occur during
the first 4-6 h (2,28), outpatient diagnostic ERCP
is thought to be a feasible and safe approach (28).
This was also true in the present study. On the other
hand, average ERCP duration was reported as 18
min by Penaloza-Ramirez et al. (2). A similar average
duration of 16.5 min was determined in our study.
The overall success rate of ERCP has ranged from
79.6% (1) to 94.6% (2); this range is compatible with
our success rate of 94.5%. On the other hand, precut
sphincterotomy was used in 0.3% of patients by Huang
et al. (1), 14.8% by Penaloza-Ramirez et al. (2), and
7.1% by Rabago et al. (28). Precut sphincterotomy was
required in 14.8% of our patients. Although precut
sphincterotomy has a morbidity rate itself (29), it
may increase the ERCP success rate; this was shown
by Huang et al. (1) and Wang et al. (30) as well as in
our study. The major reasons for cannulation failure
in ERCP include the following: obstruction due to
tumor of the papilla, biliary tract, or duodenum;
papillary constriction due to inflammation; stenosis of
the duodenal bulb; papillary location abnormalities,
including location in or around a diverticulum;
and history of a gastrectomy with Billroth II or
Roux-en-Y reconstruction (1,2,5). Incomplete
papillary obstruction or constriction problems may
be solved with precut sphincterotomy (1,21), as
performed in our study. While balloon dilatation or
antiinflammatory medication may be helpful in cases
with duodenal stenosis, clip-assisted ERCP may be
effective in patients with intradiverticular papilla
(31). Finally, ERCP may be carried out using an
end- or oblique-viewing endoscope or laparoscopyassisted transjejunal method in cases with Rouxen-Y reconstruction (32,33). On the other hand,

pregnancy is a limitation of ERCP, and therapeutic
nonradiation ERCP with wire-guided cannulation
may be performed in selected pregnant women (34).
Complications associated with ERCP have
been reported at as high as 12.1%, with a mean of
4.0% (1,2,28,35,36). Major complications are seen
in patients with severe and incapacitating systemic
diseases, obesity, known or suspected bile duct stones,
pancreatic manometry, and complex procedures (35).
Acute pancreatitis is the most common complication
after ERCP, with reported frequencies that range from
0.9% to 4.4%. Predictors of acute pancreatitis include
the presence of pancreatic duct catheterization,
roentgenography, sphincterotomy, or suspected
sphincter of Oddi dysfunction (1,2,28,35-37).
Bleeding risk during ERCP is 0.3%-1.3%, and this rate
is even higher with sphincterotomy and in patients
undergoing anticoagulant therapy (1,2,35,36,38). The
risk of perforation during ERCP is 0.3%-1.3%, and, like
the risk of bleeding, it is higher with sphincterotomy,
stenting, and biliary or gastric Roux-en-Y diversion
(1,2,35,36). Acute cholangitis is seen in 0.4%-1.8% of
ERCP patients, and this rate is even higher in patients
with incomplete biliary obstruction (1,2,28,36). On
the other hand, premedication problems, such as
intolerance to sedation, arrhythmias, and respiratory
or cardiac arrest, may develop in 0.5%-1.0% of cases
(2), while systemic air embolism is a rare complication
of ERCP (39). The rate of mortality associated with
ERCP has been reported at up to 1.0% with a mean
of 0.4% (1,28). In our study, when serum amylase
level elevation was excluded, the complication and
mortality rates were on the lower end of the rates
reported in the literature. In our experiences, general
surgeons may have some advantages in recognizing
and treating the surgically treated complications of
ERCP.
In conclusion, despite its associated morbidity
and risk of mortality, ERCP is a reliable method in
diagnosing and treating hepatobiliary and pancreatic
diseases.
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